CS Paper Radar

Benchmarking CNNs, Vision Transformers, and Foundation Models for Explainable Brain Tumor MRI Classification: Calibration, Decision Analysis, and External Validation

Akwasi Asare

cs.CV ·submitted 2026-11-09 02:51 UTC · v1

Abstract

Deep learning models for brain tumor MRI classification are usually compared by accuracy alone, on public datasets whose independence is rarely checked. We benchmarked six architectures: two convolutional networks (EfficientNetV2-M and ConvNeXt-V2-Tiny), two vision transformers (Swin-V2-S and ViT-L/16), and two foundation models (DINOv2-L and MedSigLIP-448), for four-class classification of 7,216 public MRI images. We assessed accuracy, calibration, explainability, ensembles, and decision curves, with every fitted quantity estimated on validation data only. Pixel-verified duplicate screening showed that 36% of the test images had a near-duplicate in the training data. Test accuracy ranged from 94.5% to 95.6%, with no pairwise difference after Holm correction, and fell to 90.3% to 91.7% on the 773 test images free of duplicates and shared patients. Ensembles did not outperform the best single model. Attribution maps passed a model-randomization test but localized expert-annotated tumors poorly. On 1,675 external BDNeuro-MRI images that did not duplicate the training data, accuracy ranged from 77.6% (MedSigLIP-448) to 95.0% (ViT-L/16), and 12 of 15 pairwise differences were significant. Internal accuracy on this public collection therefore did not distinguish the architectures, whereas the duplicate-filtered external test did.

Comment
Under review at Scientific Report Journal, Springer

Closest papers

Nearest neighbours by meaning across the whole index.

A Trustworthy Clinical Decision Support Framework for Brain Tumor MRI Classification: Integrating Attention-Guided Learning, Explainable AI, and Out-of-Distribution Validation

cs.CV cs.AIcs.LG ·2026-10-06 ·Arjun Kumar Gupta, Harminder Pal Monga
publishedbenchmark similarity 0.75
Abstract · Accepted for presentation at the IC3AI-2026 IEEE conference in Dec 2026. It has been accepted/selected but is not yet published. 6 pages, 4 …

Deep learning models for brain tumor diagnosis need to do more than achieve high classification accuracy. For practical use, they should also provide understandable predictions, recognize unsuitable inputs, and work within a usable clinical system. This paper presents a framework for classifying brain MRI into four categories: glioma, meningioma, pituitary tumor, and no tumor. The model uses InceptionResNetV2 with a Convolutional Block Attention Module (CBAM), while Grad-CAM provides visual explanations of its predictions. A two-stage out-of-distribution (OOD) mechanism screens unsuitable inputs using an initial grayscale check followed by Mahalanobis distance, softmax confidence, and predictive entropy. These components are brought together in NeuroScan AI, a real-time web application. Evaluated on a Mendeley brain tumor MRI dataset of 12,064 images, the framework achieved 98.70% validation accuracy, 96.73% test accuracy, and a macro-average AUC of 0.9965. The OOD pipeline achieved 99% detection accuracy on a preliminary 100-image benchmark. Grad-CAM visualizations showed qualitative correspondence with clinically established tumor locations across all four classes. Overall, the work brings classification, explainability, input validation, and deployment into one framework, while recognizing that broader clinical and OOD validation is still required.

0.25

How Robust Are CNNs and Vision Transformers for Alzheimer's MRI Classification Across Datasets?

cs.CV ·2026-10-24 ·Hafija Aktar, Molly Croes, Frank S. Menniti, Abdeltawab Hendawi
dataset similarity 0.74
Abstract · 12 pages, 9 tables, 3 figures. Submitted to Biomedical Signal Processing and Control

Accurate assessment of Alzheimer's disease stages from MRI is important for understanding disease progression and supporting the development of computer-aided analysis tools. Deep learning models have shown promising results for Alzheimer's disease classification from MRI. However, when evaluated on single datasets, it is difficult to determine whether the observed performance reflects consistent architectural behavior or dataset-specific effects. In this work, we present a multi-dataset benchmarking framework with standardized preprocessing and evaluation. We compare five architectures: ResNet-50, ReXNet-150, Swin Transformer, ViT-Base, and ViT-Large. The models are evaluated across three MRI datasets representing severe class imbalance, train-test distribution mismatch, and large-scale augmentation. The results show broadly consistent performance patterns across datasets, with ViT-Large achieving the best performance on all three datasets and reaching up to 99.84% accuracy and 99.86% macro F1. Performance differences between architectures are most pronounced under distribution mismatch and considerably smaller in the augmented-data setting. Across datasets, lower class-level performance is observed primarily among adjacent early-stage categories, particularly Very Mild and Mild impairment. These findings highlight the importance of evaluating deep learning architectures across multiple data conditions rather than relying on single-dataset performance.

0.20

BrainAid: Efficient Brain Tumor Detection Using Lightweight CNNs and Explainable AI for Resource-Constrained Environments

cs.CV ·2026-10-10 ·Sai Sriram Gonthina, Ross Gore, Bikash Chandra Singh, Pronaya Bhattacharya, Sachin Shetty +2 more
similarity 0.74
Abstract

A brain tumor is an unusual growth of cells in the brain that can be cancerous or not, affecting normal brain function and causing serious risk to health. Existing solutions for brain tumor classification, such as expert manual evaluations of magnetic resonance imaging (MRI) scans, are generally inconsistent as different professionals have different criteria and can be resource-intensive, leading to delayed diagnoses. Additionally, while deep learning models have demonstrated potential, they typically require significant computational resources, motivating the need for more efficient and accessible diagnostic tools that can be deployed in real-time healthcare settings. To address these limitations, this study presents BrainAid, which makes efficient use of Convolutional Neural Networks (CNNs) and Vision Transformers (ViTs) for effective classification of four-class classification of glioma, meningioma, pituitary tumor, and no-tumor MRI scans, outperforming all the standard models such as VGG16, Inception-V3, ResNet-50 and so, while integrating Explainable AI (XAI) to improve interpretability. The BrainAid is trained to classify tumors with a high precision of 98%, achieving an F1 score of 98% and an accuracy of 98% using publicly available dataset. The model is deployed on a Raspberry Pi, demonstrating efficiency in low-resource environments. This system shows the feasibility of real-time, edge-based tumor classification, providing quick diagnostic support for medical professionals and enhancing patient care in resource-limited healthcare facilities and underserved areas.

0.07

Explainable and CPU-Efficient Brain Tumor Classification from MRI Using Two-Phase EfficientNetB3 Fine-Tuning

cs.CV ·2026-11-18 ·Deepro Das, Saad Kabir Uddin, Mohammad Alauddin, Bornali Sarker, Thasnim Akhter
similarity 0.73
Abstract · 6 pages, 5 figures, 6 tables

Brain tumors are among the most lethal neurological disorders, with over 308,000 new diagnoses annually worldwide. Accurate classification of tumor type from Magnetic Resonance Imaging (MRI) scans is critical for treatment planning; however, manual radiological interpretation is time-consuming and prone to inter-observer variability. This paper proposes an automated deep learning pipeline for four-class brain MRI classification (glioma, meningioma, no tumor, and pituitary tumor) using EfficientNetB3 transfer learning with a custom classification head. A two-phase training strategy is adopted: Phase 1 trains the head with a frozen backbone (best validation accuracy: 92.77%), and Phase 2 selectively fine-tunes the top 37 layers at a 100x reduced learning rate (best validation accuracy: 94.91%). On an independent balanced test set of 1,600 MRI images, the system achieves 90.62% overall accuracy and a macro-average AUC of 0.9854. Gradient-weighted Class Activation Mapping (Grad-CAM) is integrated for class-discriminative visual explainability. The proposed system simultaneously addresses three dimensions absent in prior work: high accuracy, CPU-only computational efficiency, and clinical interpretability.

0.14

A comparison of CNN architectures for Alzheimer's disease detection in single-view MRI scans

eess.IV cs.CVcs.LG ·2026-08-12 ·Hiram Zuniga, Ulises Orozco-Rosas, Kenia Picos
publishedbenchmark similarity 0.71
Abstract · Accepted at SPIE Optics + Photonics 2026 for oral presentation. 14 pages, 7 figures, 8 tables

Alzheimer's disease is a leading cause of death with no cure. Therefore, early detection is critical to slow progression and preserve quality of life. Diagnosis relies on medical history, cognitive tests, physical exams, and MRI brain scans, making deep learning suitable for Alzheimer's classification. This work proposes a benchmark that evaluates ten different convolutional neural network (CNN) architectures (including ResNet, DenseNet, MobileNet, EfficientNet, and VGG family models) under the same held-out test split protocol. A two-stage transfer learning and full fine-tuning pipeline is introduced to perform training using a class-balanced subset (3,900 images) derived from the OASIS medical imaging dataset, comprising 86,437 single-view MRI brain scans labeled into four classifications of Alzheimer's disease: Non-Demented, Very Mild Dementia, Mild Dementia, and Moderate Dementia. The best results were achieved by VGG16, with a 0.9637 validation accuracy and a 0.9533 test accuracy score. A key finding documented in this work is the difficulty of classifying the transition from Non-Demented to Very Mild Demented stages, observed consistently across all ten architectures.

0.28

NanoNet: Ultra-Lightweight Network for MRI Brain Tumor Classification toward Edge AI

cs.CV ·2026-11-08 ·Tran Nguyen-Le, Huu-Thuan Huynh, Minh-Triet Tran, Trung-Nghia Le
benchmark similarity 0.69
Abstract

Automated brain tumor classification from magnetic resonance imaging (MRI) can support accessible medical image analysis, but conventional deep learning models often exceed the resource budgets of highly constrained edge-AI platforms. We present NanoNet, an ultra-lightweight convolutional neural network designed for resourceconstrained MRI classification and motivated by future edge-AI applications. Inspired by MobileNetV2, NanoNet substantially reduces network depth, channel capacity, expansion ratios, and final feature dimensionality, resulting in only five inverted residual blocks and 8,132 parameters. We further investigate dependency-aware structured pruning, knowledge distillation, and INT8 quantization-aware training for additional compression. Experiments on the BRISC 2025 benchmark show that NanoNet achieves 92.80% accuracy and 92.97% macro F1 with 8,132 parameters and 10.498 MFLOPs. Across three compression seeds, it exceeds the mean accuracy of 70%-pruned MobileNetV2 by 5.20 percentage points while using 60.2% fewer parameters and 9.8% less computation. Converted INT8 NanoNet achieves 89.70% accuracy and 90.22% macro F1 across three QAT seeds. Earlier TensorFlow Lite measurements indicate 27.7 KB of baseline model storage, motivating future edge-AI deployment.

0.12

Does DCGAN-Based Synthetic Augmentation Improve Brain Tumor MRI Classification? An Empirical Study

eess.IV cs.CV ·2026-09-20 ·Irhum Jawad Khan, Talha bin Aslam
similarity 0.69
Abstract

Generative adversarial networks (GANs) are increasingly used to augment medical imaging datasets, but synthetic images do not necessarily provide downstream classification benefits. This study investigates whether class-specific Deep Convolutional Generative Adversarial Network (DCGAN) augmentation improves brain tumor classification when the classifier and evaluation set are held constant. Experiments were conducted on 7,200 brain magnetic resonance imaging (MRI) scans across four classes: glioma, meningioma, pituitary tumor, and no tumor. For each class, 1,400 real images were used for training and 400 were reserved for testing. A baseline Swin Transformer classifier was trained using only the real training images and compared with a second model trained using the same real images augmented with 500 DCGAN-generated images per class. Both conditions were evaluated on the identical held-out test set. The two models achieved the same overall accuracy of 96%, while macro F1 remained effectively unchanged and ROC-AUC decreased slightly from 0.987 to 0.982 after augmentation. Class-level analysis showed small redistributions in errors rather than a consistent performance gain. FID values between real and synthetic images ranged from 209.15 to 314.27, indicating substantial distributional differences under the adopted evaluation setup. These results suggest that synthetic augmentation should not be assumed to improve medical image classification and should instead be evaluated for both distributional fidelity and downstream task utility.

0.18

Interpretable Deep Learning Models for Breast Cancer Diagnosis Using Medical Imaging

cs.CV cs.AI ·2026-10-27 ·Sami Alnawali, Muhammad Atif Saeed, Abdul Hadi, Azka Atiq, Akhtar Jamil +1 more
benchmark similarity 0.69
Abstract · 37 page, 45 Figures

Deep learning shows promise for breast cancer diagnosis, but limited interpretability hinders clinical adoption. We benchmark ten ImageNet-pretrained models (ResNet50, VGG19, InceptionV3, DenseNet121, Xception, MobileNetV2, EfficientNet, ConvNeXt, ViT, and Swin Transformer) for benign-versus-malignant classification on the BreakHis histopathology dataset using a patient-level split, and explain their predictions with Grad-CAM, LIME, Integrated Gradients, and LRP. DenseNet121 performed best, with 99.4% test accuracy and an AUC-ROC of 0.999, and significantly outperformed all other models (p < 0.001). Transformer-based models trailed the CNNs. The explanations consistently highlighted nuclei-rich and glandular regions of diagnostic relevance. Combining transfer learning with explainable AI can thus yield accurate, interpretable tools for breast cancer diagnosis.

0.19